Enhanced Green Fluorescent Protein, EGFP (200 - 208)

Description:

This peptide serves as a model tumor antigen for the experimental development of antigen-specific vaccines against cancer.

Sequence:

HYLSTQSAL

General

References

Comments (0)

Name	Enhanced Green Fluorescent Protein, EGFP (200 - 208)
Category	Cancer Research Peptides
One Letter Code	HYLSTQSAL
Three Letter Code	{His}{Tyr}{Leu}{Ser}{Thr}{Gln}{Ser}{Ala}{Leu}
Molecular Weight	1019.100
Application	Cancer Research

Wysocki, Piotr J., et al. "Captopril, an angiotensin-converting enzyme inhibitor, promotes growth of immunogenic tumors in mice." Clinical cancer research 12.13 (2006): 4095-4102.

Sharma, Sanjay, Ana Lucia Dominguez, and Joseph Lustgarten. "High accumulation of T regulatory cells prevents the activation of immune responses in aged animals." The Journal of Immunology 177.12 (2006): 8348-8355.

Wingender, Gerhard, et al. "Systemic application of CpG‐rich DNA suppresses adaptive T cell immunity via induction of IDO." European journal of immunology 36.1 (2006): 12-20.

Gambotto, A., et al. "Immunogenicity of enhanced green fluorescent protein (EGFP) in BALB/c mice: identification of an H2-K d-restricted CTL epitope." Gene therapy 7.23 (2000): 2036-2040.